Current Investigations

Herman Jones LLP is currently investigating the following matters.

For more information,
please click on one of the press releases below.

Herman Jones LLP Announces Investigation for Investors in Twitter

June 17, 2022

Herman Jones LLP is investigating claims for investors who may have been harmed by Twitter's possibly overstating its real account users. Recently, a lawsuit was filed in the Chancery Court of Delaware against Twitter. A shareholder alleges, among other claims, that for years Twitter has overstated its number of real daily active users and has driven up its revenue by failing to identify its actual volume of fake accounts...

Herman Jones LLP Announces Investigation for Investors in Ericsson

June 17, 2022

Herman Jones LLP is investigating claims for investors who may have been harmed by Ericsson's possible breaches of compliance rules. A class action lawsuit was recently filed in federal court on behalf of purchasers of the securities of Ericsson for violations of the Securities Act of 1933 in relation to what have been alleged as “serious” breaches of various compliance rules. According to the Complaint, Ericsson engaged in paying tens of millions of dollars in questionable payments which were not previously disclosed...

Herman Jones LLP Announces Investigation for Investors in AbbVie Inc.

June 17, 2022

Herman Jones LLP is investigating claims for investors who may have been harmed by AbbVie's alleged statements about Its drug Rinvoq. A shareholder class action complaint was recently filed in federal court, contending that AbbVie violated the 1933 Securities Act by misleading investors relating to the prospects of its drug Rinvoq. When the FDA announced it would not complete its review of various expanded indications of Rinvoq by the end of June 2021 due to safety concerns and the drug would be limited as a result, the stock price was adversely impacted...